Perth-based biomedical technology firm Phylogica has raised $5.2 million through a share placement to institutional and sophisticated investors it said was heavily oversubscribed.

Perth-based biomedical technology firm Phylogica has raised $5.2 million through a share placement to institutional and sophisticated investors it said was heavily oversubscribed.